ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
source: pixabay.com

ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder

Health Canada has recently granted market authorization to Hoffman La-Roche Limited for their neuromyelitis optica spectrum disorder treatment, ENSPRYNG. Canada is the first country to offer this medication, and hopefully…

Continue Reading ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
https://pixabay.com/photos/swing-playground-children-playing-1188132/

Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida

Dayton Abbott is like many kindergarteners; she loves to tell jokes, play games, and hang out with friends during recess. But her playground at Alexander Elementary School wasn't built for…

Continue Reading Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease

Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

According to an article from Newswire, the Alzheimer's Association is awarding Elixiron Immunotherapeutics one million dollars for work on their Alzheimer's treatment, EI1071. This money will go towards a clinical…

Continue Reading Grant Goes to Elixiron Immunotherapeutics for Alzheimer’s Disease Treatment

Joint Efforts by Korean and California Research Teams Develop A Drug That Restores Renal Intervascular Cell Function

A recent article in the Korea Biomed Review reported that the joint research effort by Seoul National Medical College and Helixmith of San Diego, California, found Helixmith’s VM507 antibody effective…

Continue Reading Joint Efforts by Korean and California Research Teams Develop A Drug That Restores Renal Intervascular Cell Function